Loading ACAD...
Acadia Pharmaceuticals Inc.ACADAs of 31 July 2026
Public engagement data
Reactive Search·
Cumulative Search·
Investigative Research·
−300−1500+150+300
74
PositiveNegative
Positive skew
CheapExpensive
FearGreed
WeakStrong
Emotion

Is Acadia Pharmaceuticals Inc. oversold, or is the crowd euphoric?

A read on the market's emotion around Acadia Pharmaceuticals Inc. (ACAD): where sentiment sits between capitulation and euphoria, measured against the stock's own history so heavily covered and quieter names read on the same scale. Information, not advice.

Acadia Pharmaceuticals Inc.ACADLast 5 years
VEFA
ACAD priceasymmetryquant.com